The rap from both the US and UK drug regulators, including the latest one from the latter, has hit the scrip.
With this allocation of portfolios, the Sharad Pawar-led NCP has got most of the 'plum' ministries.
The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the United States.
The US laws authorise the drug and health watchdog to assess and collect user fees for certain applications and supplements for human generic drug products
OBC leader Dharam Singh Saini on Thursday became the third minister to resign from the Uttar Pradesh cabinet this week, giving yet another jolt to the ruling Bharatiya Janata Party in the run-up to the assembly polls.
At least 85 people have died of coronavirus with the confirmed cases crossing 4,500 in the US.
The merger has fortified Sun Pharma's position.
At $37 per dose, the Pfizer vaccine is much more expensive compared to $3 per dose for the Covishield.
The vaccine arrives at a critical moment for the US. Hospitalisations due to COVID-19 hit record highs for the seventh day in a row on Saturday.
"Due to scheduling reasons, it is inconvenient for China to attend the meeting," Chinese Foreign Ministry spokesman Wang Wenbin told mediapersons.
Nestl India is preparing a blueprint for a possible relaunch.
These vaccines have not yet been approved by the World Health Organization
A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory non-compliance can have on operations.
Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.
Trump also raised the possibility of using light to combat the deadly viral infection.
Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.
The US Food and Drug Administration said on Sunday that over 70,000 patients in the country had been treated with convalescent plasma, which is made using the blood of people who have recovered from coronavirus infections.
The BSE Midcap also cut all its intraday gains to shed 0.3% at close
Analysts are eyeing bigger launches that will positively impact company's fortunes.
Many countries found Maggi noodles to be safe for consumption.
Altaf Ahmed Lal, country head of the US Food and Drug Administration (US FDA) in India, has quit and so have a few other key officials at the American drug regulator's India office.
The names of two Indian-Americans -- Seema Verma and Bobby Jindal -- have emerged as possible candidates.
'The Centre and state need to take a unified approach and take concerted action before this matter assumes menacing proportions because unemployment, the drug trade and the levels of frustration among the youth make them vulnerable to any maverick who promises something better.'
Low growth visibility and trouble with regulators have resulted in lack of interest from investors
The news that exports to the US will not restart before next year as well as the September quarter performance are sentiment dampeners.
Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.
To focus on molecules at advanced stage of development; move to impact 200 scientists.
Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.
The company has received a communication from the Medicines and Healthcare Products Regulatory Agency, United Kingdom, whereby the agency has decided to withdraw the previously issued GMP Certificate to the company's manufacturing facility situated at Kadaiya, Nani Daman, Wockhardt said in a filing to the Bombay Stock Exchange.
The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it
This is not just a Ranbaxy or Wockhardt problem, says K Satish Reddy
The global heath body had earlier suspended the hydroxychloroquine arm of the clinical trials of experimental COVID-19 drugs over safety concerns.
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
Gujarat has around 3,000 licensees for allopathic drug manufacturing, apart from around seven homeopathic licensees, 500 ayuvedic and 600-700 cosmetics licensees
Test reports from UP food regulator started the controversy.
Five days after the induction of 18 ministers into his cabinet, Maharashtra Chief Minister Eknath Shinde on Sunday allocated portfolios, keeping Urban Development and 11 other ministries with himself, while giving the crucial Home Department to Deputy CM Devendra Fadnavis.
The under-one-minute films are titled 'Menu Cards, Mom and Neighbours'.
Of the 30-share Sensex pack, 22 ended with losses while NTPC ended flat at Rs 127.30.
The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.
Roadshows will be held in Singapore, Hong Kong, London, New York and Boston, NTPC gained close to 1%.